The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
The meeting report has just been published for our 9th Biennial Signal Detection Conference, which took place in June. The report details some of the highlights and themes of the event, including Signal Detection in the Age of Big Data, new methodologies and updates on well-established approaches. DSRU Signal Detection Conferences have built up a loyal following amongst the Signal Detection community worldwide, since the first event was held in 2001.
Read the report here: http://rdcu.be/uR2t
The next Signal Detection conference is due to take place in summer 2019, but watch this space for details of our new “Big Data in Pharmacovigilance” conference next summer!View our latest news
The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]View all our latest questions